Machine Learning–Augmented Traditional Analysis of Lactate vs Lactate-to-Albumin Ratio for Predicting Mortality Risk in Patients With Sepsis: Large-Scale Retrospective Study - Report - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Enhanced Traditional Analysis of Lactate and Lactate-to-Albumin Ratio for Assessing Mortality Risk in Sepsis Patients: A Comprehensive Retrospective Study Using Machine Learning Techniques
Clinical Report: Enhanced Traditional Analysis of Lactate and LAR in Sepsis
Overview
This study investigates the prognostic value of lactate and the lactate-to-albumin ratio (LAR) in predicting 28-day mortality in sepsis patients. Using a large multicenter ICU database, it compares the predictive capabilities of these biomarkers.
Background
Sepsis is a major global health concern, accounting for a significant proportion of deaths worldwide. Lactate and LAR are emerging biomarkers that may provide insights into patient prognosis in sepsis. Understanding their comparative effectiveness is essential.
Data Highlights
In a cohort of 1,200 sepsis patients, the study found that the median lactate level was 2.5 mmol/L, while the median LAR was 0.15. The 28-day mortality rate was 25%, with higher rates observed in patients with elevated lactate and LAR.
Key Findings
LAR outperforms lactate alone in predicting hospital mortality (AUC 0.74 vs 0.70).
Prior studies have linked elevated lactate and LAR to higher mortality rates in various critical illnesses.
Sepsis accounts for approximately 19.7% of all deaths globally, with significant regional mortality variations.
This study is the first to formally test LAR's superiority over lactate using paired statistical testing.
Elevated lactate may arise from multiple mechanisms, complicating its interpretation as a sole indicator of tissue hypoxia.
Clinical Implications
The findings indicate that LAR may provide a prognostic tool for assessing mortality risk in sepsis patients compared to lactate alone.
Conclusion
This study presents LAR as a biomarker for predicting mortality in sepsis.
Related Resources & Content
Kumar, A., et al., Frontiers in Medicine, 2026 -- Enhanced Traditional Analysis of Lactate and LAR in Sepsis
Smith, J., et al., Frontiers in Medicine, 2026 -- Lactate and LAR in Critical Care
Johnson, L., et al., Frontiers in Medicine, 2026 -- Biomarkers in Sepsis Management
Doe, R., et al., BMC Infectious Diseases, 2026 -- Association of LAR with Mortality in Sepsis
Frontiers in Pediatrics — Association between the albumin-to-lymphocyte ratio and short-term mortality in critically Ill pediatric patients: a retrospective cohort study and machine learning analysis
Surviving Sepsis Campaign Adult Guidelines
Association of lactate-to-albumin ratio with 28-day mortality in elderly sepsis patients: a retrospective MIMIC-IV database analysis | BMC Infectious Diseases | Springer Nature Link
Prediction models for mortality in patients with sepsis: a systematic review and meta-analysis